The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Core Laboratories NV

NYSE: CLB
Last

(U.S.) $89.81

Today's change+0.75 +0.84%
Updated August 22 4:01 PM EDT. Delayed by at least 15 minutes.
 

Core Laboratories NV

NYSE: CLB
Last

(U.S.) $89.81

Today's change+0.75 +0.84%
Updated August 22 4:01 PM EDT. Delayed by at least 15 minutes.

Core Laboratories NV up (U.S.)$0.75

Core Laboratories NV closed up Tuesday by (U.S.)$0.75 or 0.84% to (U.S.)$89.81. Over the last five days, shares have lost 0.18% and sit 2.25% above their 52-week low. This security has underperformed the S&P 500 by 35.06% during the last year.

Key company metrics

  • Open(U.S.) $89.24
  • Previous close(U.S.) $89.06
  • High(U.S.) $89.84
  • Low(U.S.) $88.96
  • Bid / Ask-- / --
  • YTD % change-25.18%
  • Volume300,531
  • Average volume (10-day)545,824
  • Average volume (1-month)921,061
  • Average volume (3-month)711,577
  • 52-week range(U.S.) $87.83 to (U.S.) $125.83
  • Beta1.63
  • Trailing P/E54.91×
  • P/E 1 year forward42.91×
  • Forward PEG0.84×
  • Indicated annual dividend(U.S.) $2.20
  • Dividend yield2.45%
  • Trailing EPS(U.S.) $1.64
Updated August 22 4:01 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.22%Sector:EnergyIndustry:Oil Related Services & Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue164158150143
Total other revenue--------
Total revenue164158150143
Gross profit47433736
Total cost of revenue117115113107
Total operating expense134135128122
Selling / general / administrative111398
Research & development--------
Depreciation / amortization6677
Interest expense (income), net operating--------
Unusual expense (income)0100
Other operating expenses, total0000
Operating income29232221
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax27211919
Income after tax23181517
Income tax, total4342
Net income23181517
Total adjustments to net income--------
Net income before extra. items23181517
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items23181517
Inc. avail. to common incl. extra. items23181517
Diluted net income23181517
Dilution adjustment--------
Diluted weighted average shares44444444
Diluted EPS excluding extraordinary itemsvalue per share0.510.400.350.38
Dividends per sharevalue per share0.550.550.550.55
Diluted normalized EPSvalue per share0.510.420.350.38